Inhibitor Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2012 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Inhibitor Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q3 2024.
Inhibitor Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$813K, a 7.07% decline year-over-year.
Inhibitor Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.45M, a 34.9% decline year-over-year.
Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$3.4M, a 418% decline from 2022.
Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$658K, a 102% decline from 2021.
Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$325K, a 69.3% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$3.45M	-$813K	-$53.7K	-7.07%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$3.39M	-$585K	+$157K	+21.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	-$3.55M	-$775K	-$145K	-23%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	-$3.4M	-$1.27M	-$850K	-201%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-29
Q3 2023	-$2.56M	-$760K	-$690K	-985%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	-$1.87M	-$742K	-$672K	-949%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	-$1.19M	-$630K	-$536K	-574%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	-$658K	-$424K	-$395K	-1373%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-29
Q3 2022	-$263K	-$70K	-$3.74K	-5.64%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$259K	-$70.8K	-$8.17K	-13%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$251K	-$93.5K	+$74.3K	+44.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$325K	-$28.8K	+$27K	+48.4%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$352K	-$66.2K	+$237K	+78.1%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$589K	-$62.6K	+$252K	+80.1%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12
Q1 2021	-$841K	-$168K	+$218K	+56.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-13
Q4 2020	-$1.06M	-$55.7K	+$582K	+91.3%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-30
Q3 2020	-$1.64M	-$303K	+$380K	+55.7%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$2.02M	-$315K	+$320K	+50.4%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	-$2.34M	-$385K	+$406K	+51.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	-$2.75M	-$638K	+$692K	+52%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-26
Q3 2019	-$3.44M	-$683K	+$493K	+41.9%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019	-$3.93M	-$636K	+$249K	+28.1%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019	-$4.18M	-$792K	+$383K	+32.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	-$4.56M	-$1.33M	-$424K	-46.8%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-30
Q3 2018	-$4.14M	-$1.18M	-$494K	-72.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	-$3.65M	-$884K	-$165K	-22.9%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018	-$3.48M	-$1.17M	+$1.64M	+58.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	-$5.12M	-$905K	+$1.86M	+67.2%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-07
Q3 2017	-$6.98M	-$681K	+$1.05M	+60.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$8.03M	-$719K	+$611K	+45.9%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-23
Q1 2017	-$8.64M	-$2.81M	-$1.62M	-136%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-01
Q4 2016	-$7.02M	-$2.76M	-$1.73M	-167%	Oct 1, 2016	Dec 31, 2016	10-K	2018-02-16
Q3 2016	-$5.29M	-$1.73M	-$532K	-44.3%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016	-$4.76M	-$1.33M	-$538K	-68%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-31
Q1 2016	-$4.22M	-$1.19M	-$272K	-29.5%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-08
Q4 2015	-$3.95M	-$1.03M	-$136K	-15.2%	Oct 1, 2015	Dec 31, 2015	10-K	2017-02-17
Q3 2015	-$3.81M	-$1.2M	-$464K	-62.9%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-31
Q2 2015	-$3.35M	-$792K	+$1.32M	+62.6%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-12
Q1 2015	-$4.67M	-$923K	-$736K	-394%	Jan 1, 2015	Mar 31, 2015	10-Q	2015-05-13
Q4 2014	-$3.94M	-$897K	-$684K	-321%	Oct 1, 2014	Dec 31, 2014	10-K	2016-02-01
Q3 2014	-$3.25M	-$738K	+$554K	+42.9%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-04
Q2 2014	-$3.81M	-$2.12M	-$1.71M	-424%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-14
Q1 2014	-$2.1M	-$187K	-$96.4K	-106%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-13
Q4 2013	-$2M	-$213K			Oct 1, 2013	Dec 31, 2013	10-K	2015-02-13
Q3 2013		-$1.29M	-$1.15M	-840%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-10
Q2 2013		-$404K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-13
Q1 2013		-$90.5K			Jan 5, 2013	Mar 31, 2013	10-Q	2014-05-12
Q3 2012		-$137K			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.